Aim: The purpose of this study was to use measurements from cone beam computed tomography scans to quantify the cortical bone thickness of mandibular buccal shelf region and preferable site for buccal shelf implant placement in 10 hyperdivergent and 10 hypodivergent patients. Method: 20 cone beam computed tomographies were equally divided based on divergence. 6 sites were examined: mesial of first molar (6M), middle of first molar (6Mi), interdental between the first and second molar (Id), mesial of second molar (7M), middle of second molar (7Mi), and distal of second molar (7D). The study quantified the mandibular buccal shelf relative to its angle of slope, the cortical bone thickness measured perpendicular to the bone surface, the amount of cortical bone 30° angle to the bone surface. The cortical bone thickness was measured perpendicular and at a 30° angle at 3, 5, and 7 mm from the alveolar crest. Result: Significant change is seen at the buccal shelf slope at 6M ( P = .001) and further increase in this angle till 7D ( P = .003). Mean amount of cortical bone for hyperdivergent group at 7D is 4.77 ± 0.68 mm and for hypodivergent group is 3.86 ± 0.70 mm. Statistically significant differences were noted at insertion site at 90° and 30° for both groups at 3, 5, and 7 mm from the alveolar crest. Conclusion: Preferable site for buccal shelf implant placement is distal to the mandibular second molar. The maximum amount of cortical bone is found distal to the second molar 7 mm vertically from alveolar crest when the buccal shelf implant is placed at 30° angulation for hyperdivergent group.
Skeletal class II malocclusion is best treated by growth modification using the myofunctional appliances or the orthopedic appliances or the combination of the both depending upon the type of malocclusion encountered during the growth period of an individual. Though all myofunctional appliances work on the same principle with few basic differences; the orthodontist has to make a choice among the plethora of the appliances at his disposal. The present article is a case report of class II malocclusion treatment using the Bass appliance for the growth modification, which was followed by fixed appliance for the occlusal detailing.
Objectives:
The objectives of the study were to assess the long-term stability of the curve of Spee leveled with continuous archwire in subjects with two different retention protocols.
Materials and Methods:
The study sample consisted of 20 patients (mean age 18 ± 2 years) presenting with curve of Spee depth of =/> 3 mm. For each subject, lateral cephalograms and dental casts were available before treatment (T1), at the end of orthodontic therapy (T2), and 1 year after the end of treatment (T3). All subjects were divided into two groups according to their retention protocol – fixed retainer group (Group-1) and Essix retainer group (Group-2). Cephalometric parameters were used to evaluate the dental movements after treatment. Curve of Spee depth was measured on standardized digital images of casts.
Results:
In multicomparison table, it shows that there was a statistically significant difference (P = 0.032) between Spee-T2 and Spee-T3 and there was no statistical difference (P = 0.159) between L1MP-T2 and L1MP-T3 in fixed retainer group. In Essix retainer group, no changes were observed from L1MP-T2 to L1MP-T3 and there was a non-significant difference found between Spee-T2 and Spee-T3.
Conclusion:
In Group-1 (fixed retainer), there is some amount of relapse or extrusion of lower incisor. In Group-2 (Essix retainer), there was not any change in the position of the lower incisor, which suggests that occlusal coverage of the Essix retainer does not allow any extrusion and retains the curve of Spee.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.